Are Uric Acid Level and Uric Acid/Creatinine Ratio Reliable Biomarkers for Idiopathic Parkinson’s Disease Severity?

Aim:It has been proposed that elevated levels of uric acid (UA) has a protective effect against the development of Idiopathic Parkinson’s Disease (IPD), however, since IPD has been found to be more common in gout patients, their relationship became controversial. Our aim was to investigate the relat...

Full description

Saved in:
Bibliographic Details
Main Authors: Vasfiye Burcu Albay, Mesude Tütüncü
Format: Article
Language:English
Published: Galenos Publishing House 2020-09-01
Series:Haseki Tıp Bülteni
Subjects:
Online Access: http://www.hasekidergisi.com/archives/archive-detail/article-preview/are-uric-acid-level-and-uric-acid-creatinine-ratio/40225
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849400224929284096
author Vasfiye Burcu Albay
Mesude Tütüncü
author_facet Vasfiye Burcu Albay
Mesude Tütüncü
author_sort Vasfiye Burcu Albay
collection DOAJ
description Aim:It has been proposed that elevated levels of uric acid (UA) has a protective effect against the development of Idiopathic Parkinson’s Disease (IPD), however, since IPD has been found to be more common in gout patients, their relationship became controversial. Our aim was to investigate the relationship of UA level and UA-to-creatinine ratio (UCR) with IPD stages and their effects on disease severity.Methods:Patients were grouped as early stage (ES) (Hoehn-Yahr (HY); 1-2), middle stage (MS) (HY; 2.5-3) and advanced stage (AS) (HY; 4-5). UA levels and UCR were compared between the groups. After age and L-dopa dose were corrected, differences between the groups were recalculated.Results:There were 39 ES, 33 MS, 28 AS patients. The mean UA level was 4.9±1.26 in ES, 5.02±1.22 in MS and 5.1±1.64 in AS (p=0.85). The mean UCR was 5.91±1.78 in ES, 6.03±1.66 in MS and 5.72±1.73 in AS (p=0.79). When corrected age was 67.42, there was no difference in UA (p=0.93), creatinine (p=0.92) and UCR (p=0.91). When corrected L-Dopa dose was 561.18, there was no difference in UA (p=0.99), creatinine (p=0.51) and UCR (p=0.21). When age and L-Dopa were corrected, there was no difference in UA (p=0.96), creatinine (p=0.82) and UCR (p=0.21).Conclusion:Despite corrected age and L-Dopa dose, UA and UCR did not differ between the stages. UA and UCR used as biomarkers of disease severity may not always yield accurate results.
format Article
id doaj-art-a0c6fd0d99694cdfb6d0d3bfa344ce43
institution Kabale University
issn 1302-0072
2147-2688
language English
publishDate 2020-09-01
publisher Galenos Publishing House
record_format Article
series Haseki Tıp Bülteni
spelling doaj-art-a0c6fd0d99694cdfb6d0d3bfa344ce432025-08-20T03:38:08ZengGalenos Publishing HouseHaseki Tıp Bülteni1302-00722147-26882020-09-0158431531910.4274/haseki.galenos.2020.590313049054Are Uric Acid Level and Uric Acid/Creatinine Ratio Reliable Biomarkers for Idiopathic Parkinson’s Disease Severity?Vasfiye Burcu Albay0Mesude Tütüncü1 Prof. Dr. Mazhar Osman Bakırköy Ruh Sağlığı ve Sinir Hastalıkları Hastanesi, Nöroloji Kliniği, İstanbul, Türkiye Prof. Dr. Mazhar Osman Bakırköy Ruh Sağlığı ve Sinir Hastalıkları Hastanesi, Nöroloji Kliniği, İstanbul, Türkiye Aim:It has been proposed that elevated levels of uric acid (UA) has a protective effect against the development of Idiopathic Parkinson’s Disease (IPD), however, since IPD has been found to be more common in gout patients, their relationship became controversial. Our aim was to investigate the relationship of UA level and UA-to-creatinine ratio (UCR) with IPD stages and their effects on disease severity.Methods:Patients were grouped as early stage (ES) (Hoehn-Yahr (HY); 1-2), middle stage (MS) (HY; 2.5-3) and advanced stage (AS) (HY; 4-5). UA levels and UCR were compared between the groups. After age and L-dopa dose were corrected, differences between the groups were recalculated.Results:There were 39 ES, 33 MS, 28 AS patients. The mean UA level was 4.9±1.26 in ES, 5.02±1.22 in MS and 5.1±1.64 in AS (p=0.85). The mean UCR was 5.91±1.78 in ES, 6.03±1.66 in MS and 5.72±1.73 in AS (p=0.79). When corrected age was 67.42, there was no difference in UA (p=0.93), creatinine (p=0.92) and UCR (p=0.91). When corrected L-Dopa dose was 561.18, there was no difference in UA (p=0.99), creatinine (p=0.51) and UCR (p=0.21). When age and L-Dopa were corrected, there was no difference in UA (p=0.96), creatinine (p=0.82) and UCR (p=0.21).Conclusion:Despite corrected age and L-Dopa dose, UA and UCR did not differ between the stages. UA and UCR used as biomarkers of disease severity may not always yield accurate results. http://www.hasekidergisi.com/archives/archive-detail/article-preview/are-uric-acid-level-and-uric-acid-creatinine-ratio/40225 idiopathic parkinson’s diseaseuric acidcreatininehoehn yahr
spellingShingle Vasfiye Burcu Albay
Mesude Tütüncü
Are Uric Acid Level and Uric Acid/Creatinine Ratio Reliable Biomarkers for Idiopathic Parkinson’s Disease Severity?
Haseki Tıp Bülteni
idiopathic parkinson’s disease
uric acid
creatinine
hoehn yahr
title Are Uric Acid Level and Uric Acid/Creatinine Ratio Reliable Biomarkers for Idiopathic Parkinson’s Disease Severity?
title_full Are Uric Acid Level and Uric Acid/Creatinine Ratio Reliable Biomarkers for Idiopathic Parkinson’s Disease Severity?
title_fullStr Are Uric Acid Level and Uric Acid/Creatinine Ratio Reliable Biomarkers for Idiopathic Parkinson’s Disease Severity?
title_full_unstemmed Are Uric Acid Level and Uric Acid/Creatinine Ratio Reliable Biomarkers for Idiopathic Parkinson’s Disease Severity?
title_short Are Uric Acid Level and Uric Acid/Creatinine Ratio Reliable Biomarkers for Idiopathic Parkinson’s Disease Severity?
title_sort are uric acid level and uric acid creatinine ratio reliable biomarkers for idiopathic parkinson s disease severity
topic idiopathic parkinson’s disease
uric acid
creatinine
hoehn yahr
url http://www.hasekidergisi.com/archives/archive-detail/article-preview/are-uric-acid-level-and-uric-acid-creatinine-ratio/40225
work_keys_str_mv AT vasfiyeburcualbay areuricacidlevelanduricacidcreatinineratioreliablebiomarkersforidiopathicparkinsonsdiseaseseverity
AT mesudetutuncu areuricacidlevelanduricacidcreatinineratioreliablebiomarkersforidiopathicparkinsonsdiseaseseverity